Pfizer says its antiviral pill slashes risk of severe Covid-19 by 89pc

Pfizer says its antiviral pill slashes risk of severe Covid-19 by 89pc - Hello loyal readers FeedGoogle, In the article you are reading this time with the title Pfizer says its antiviral pill slashes risk of severe Covid-19 by 89pc, We have prepared this article well for you to read and take information in it. hopefully the contents of the post Article World, what we write you can understand. Alright, happy reading.

Pfizer said it expects to manufacture 180,000 treatment courses by the end of this year and at least 50 million courses by the end of next year, including 21 million in the first half of 2022. Bourla said that, based on the better-than-expected trial results, Pfizer is considering potentially doubling next year’s manufacturing target. — Reuters pic Follow us on Instagram and subscribe to our Telegram channel for the latest updates. NEW YORK, Nov 6 — Pfizer Inc’s experimental antiviral pill to treat Covid-19 cut by 89 per cent the chance of hospitalisation or death for adults at risk of severe disease, the company said yesterday, as its CEO vowed to make this promising new weapon in the fight against the pandemic available globally as quickly as possible.The trial’s results suggest that Pfizer’s drug surpasses Merck & Co Inc’s pill, molnupiravir, which was shown last month to…